Plain-English translation of NCT06203938 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are studying whether transcranial infrared light stimulation (TILS)—delivered safely through light-emitting diodes in a headband—can help improve symptoms of autism spectrum disorder. People with autism often have less efficient energy use in parts of the brain that control attention, impulse control, and social interaction, and early research suggests this light-based treatment might help restore that function. This study will test the treatment in children, teens, and adults, comparing those who receive the active light treatment to those who wear the headband without the lights turned on.
Current treatments for autism focus mainly on behavioral therapy and managing co-occurring conditions, but there are few medical interventions targeting the underlying brain function differences in autism. This trial exists to see whether this treatment can safely and effectively improve core autism symptoms by enhancing how the brain uses oxygen.
You likely qualify if…
You likely don't qualify if…
You will visit the research lab for sessions where you wear a special headband that delivers near-infrared light (or no light, if you are in the comparison group). You will complete questionnaires and cognitive tests, and the headband will also monitor your brain activity using harmless infrared light. The study involves repeated sessions over time so researchers can track whether the treatment affects your attention, impulse control, and social skills.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
United States